1. 802 Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint blockade. (9th November 2020) Authors: Herzog, Brett; Waqar, Saiama; Devarakonda, Siddhartha; Ward, Jeffrey; Govindan, Ramaswamy; Morgensztern, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗